Expression of concern
miR-139-5p Regulates Proliferation, Apoptosis, and Cell Cycle of Uterine Leiomyoma Cells by Targeting TPD52
Paper Information
Record ID:
23950
Author(s):
Journal:
Publication Date:
October 11, 2016
Retraction Date:
July 14, 2020
(5.4 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.2147/OTT.S270251Citations (20)
20
Total Citations8
Post-Retraction(40.0%)
11
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
2
After 2+ years
1510
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Heightened TPD52 linked to metabolic dysfunction and associated abnormalities in zebrafish
Hsin-Hung Lai, Kuo‐Shyang Jeng, Chung-Tsui Huang et al. (5 authors)
Archives of Biochemistry and Biophysics
Published: Sep 2024
1510 days after retraction
Related cellular signaling and consequent pathophysiological outcomes of ubiquitin specific protease 24
Song Xiaoyang, Boyu Xia, Xinrong Gao et al. (8 authors)
Life Sciences
Published: Feb 2024
5 citations
5 citations
1318 days after retraction
MiR-125b-5p/TPD52 Axis Affects Proliferation, Migration and Invasion of Breast Cancer Cells
Yuezhen Wang, Jun Fang, Feiying Gu
Molecular Biotechnology
Published: Mar 2022
12 citations
12 citations
617 days after retraction
MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52
Yuanbo Li, Yan Sun, Zhenlu Li et al. (5 authors)
Journal of Healthcare Engineering
Open Access
Published: Feb 2022
8 citations
8 citations
582 days after retraction
miR-335-5p Inhibits Progression of Uterine Leiomyoma by Targeting ARGLU1
Wei Zhao, Yingyan Zhao, Ling Chen et al. (5 authors)
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2022
5 citations
5 citations
552 days after retraction
Expression and Clinical Significance of LncRNA ATB, LncRNA GAS5, LncRNA P21 and LncRNA MEG3 in Uterine Leiomyoma Patients
翠华 卢
Hans Journal of Surgery
Published: Jan 2022
536 days after retraction
MicroRNA-139-5p Suppresses Cell Malignant Behaviors in Breast Cancer through Targeting MEX3A
Jian Chu, Tangya Li, Lei Li et al. (4 authors)
Computational and Mathematical Methods in Medicine
Open Access
Published: Nov 2021
3 citations
3 citations
476 days after retraction
Implication of miR-126 and miR-139-5p in Plasmacytoid Dendritic Cell Dysregulation in Systemic Sclerosis
Eleni Chouri, Maojie Wang, Maarten R. Hillen et al. (18 authors)
Journal of Clinical Medicine
Open Access
Published: Jan 2021
29 citations
29 citations
200 days after retraction
Diagnostic, prognostic, and therapeutic significance of miR-139-5p in cancers
Neda Khalili, Masoud Nouri‐Vaskeh, Zahra Hasanpour Segherlou et al. (7 authors)
Life Sciences
Published: Jun 2020
24 citations
24 citations
42 days before retraction
MicroRNA‑103a‑3p promotes metastasis by targeting TPD52 in salivary adenoid cystic carcinoma
Min Fu, Chuwen Chen, Lin‐Qian Yang et al. (8 authors)
International Journal of Oncology
Open Access
Published: May 2020
24 citations
24 citations
50 days before retraction
<p>Knockdown of lncRNA <em>PCAT6</em> Enhances Radiosensitivity in Triple-Negative Breast Cancer Cells by Regulating<em> miR-185-5p</em>/<em>TPD52</em> Axis</p>
Rui Shi, Peng Wu, Miaomiao Liu et al. (5 authors)
OncoTargets and Therapy
Open Access
Published: Apr 2020
41 citations
41 citations
104 days before retraction
<p>MicroRNA-139-3p Inhibits The Growth And Metastasis Of Ovarian Cancer By Inhibiting ELAVL1</p>
Fang Xue, Qi Rong Li, Yan Xu et al. (4 authors)
OncoTargets and Therapy
Open Access
Published: Nov 2019
33 citations
33 citations
256 days before retraction
Differential MicroRNA Expression Profiles as Potential Biomarkers for Pancreatic Ductal Adenocarcinoma
Ying Zhu, J. Wang, F. Wang et al. (11 authors)
Biochemistry (Moscow)
Published: May 2019
7 citations
7 citations
440 days before retraction
miR-107 enhances the sensitivity of breast cancer cells to paclitaxel
Changpo Ma, Xuejun Shi, Wen‐Chao Guo et al. (5 authors)
Open Medicine
Open Access
Published: Jan 2019
22 citations
22 citations
560 days before retraction
Star-PAP regulates tumor protein D52 through modulating miR-449a/34a in breast cancer
Aizhu Duan, Lingmei Kong, Tao An et al. (6 authors)
Biology Open
Open Access
Published: Jan 2019
5 citations
5 citations
560 days before retraction
Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer
Ying Chen, Xiaoyun Cao, Ying‐Ni Li et al. (7 authors)
AJP Cell Physiology
Open Access
Published: May 2018
35 citations
35 citations
804 days before retraction
MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition
Qianqian Shao, Pei Zhang, Yingye Ma et al. (12 authors)
Gene
Published: Feb 2018
30 citations
30 citations
887 days before retraction
MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene
Hongbo R. Luo, Rui Yang, Chun Li et al. (7 authors)
Tumor Biology
Open Access
Published: Jul 2017
46 citations
46 citations
1109 days before retraction
Inhibition of the growth of hepatocellular carcinoma cells through fibroblast growth factor 18 suppressed by miR-139
Li Yang, Dian Yin, Yilang Wang et al. (4 authors)
Oncology Reports
Open Access
Published: Apr 2017
10 citations
10 citations
1200 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #45800
Jun 27, 2023Quick Stats
Total Citations:
20
Years Since Retraction:
5.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025